Literature DB >> 33187935

Patient-Reported outcomes of pain care research in the adult emergency department: A scoping review.

Alixandra Wong1, Joseph Potter2, Nathan J Brown3, Kevin Chu3, James A Hughes4.   

Abstract

Despite more than 30 years of research, pain in the emergency department (ED) setting is frequently undertreated. EDs prioritise process measures that often have tenuous links to patient-reported outcomes. However, process measures, such as time to the administration of first analgesic medication, are neither direct objective measures of analgesia nor appropriate surrogate markers of pain relief. Since pain is a subjective symptom that lacks an objective measure, pain research in any clinical environment, including EDs, should rely upon patient-reported outcomes. This scoping review examined patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs) of pain care in the adult emergency department at the micro, meso and macro-level over the last ten years. We reviewed pain care research conducted on adults in EDs over the last ten years and identified 57 articles using 14 patient-reported outcomes of pain care falling into five broad areas, most without validation or adaption to the ED setting. Despite efforts made to incorporate PROs and PROMs into acute pain care research in the ED over the last ten years, there is still no gold-standard PROM in widespread use. We recommend the adaptation of existing tools with rigorous validation in ED populations.
Copyright © 2020 College of Emergency Nursing Australasia. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Emergency department; Pain and symptom management; Patient-Reported outcome; Patient-Reported outcome measure; Scoping review

Year:  2020        PMID: 33187935     DOI: 10.1016/j.auec.2020.10.003

Source DB:  PubMed          Journal:  Australas Emerg Care        ISSN: 2588-994X


  1 in total

1.  Intravenous acetaminophen does not reduce morphine use for pain relief in emergency department patients: A multicenter, randomized, double-blind, placebo-controlled trial.

Authors:  Bruno Minotti; Gregory Mansella; Robert Sieber; Alexander Ott; Christian H Nickel; Roland Bingisser
Journal:  Acad Emerg Med       Date:  2022-05-22       Impact factor: 5.221

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.